Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II
about
Hexokinase II knockdown results in exaggerated cardiac hypertrophy via increased ROS productionLipid-induced insulin resistance affects women less than men and is not accompanied by inflammation or impaired proximal insulin signalingReduction in hexokinase II levels results in decreased cardiac function and altered remodeling after ischemia/reperfusion injury.Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction.Mitochondrial antioxidative capacity regulates muscle glucose uptake in the conscious mouse: effect of exercise and diet.Using a novel coculture model to dissect the role of intramuscular lipid load on skeletal muscle insulin responsiveness under reduced estrogen conditions.Four grams of glucose.Lipid and insulin infusion-induced skeletal muscle insulin resistance is likely due to metabolic feedback and not changes in IRS-1, Akt, or AS160 phosphorylationMesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart.Retention of acetylcarnitine in chronic kidney disease causes insulin resistance in skeletal muscleThe physiological regulation of glucose flux into muscle in vivo.Increased N-Acetyltaurine in the Skeletal Muscle After Endurance Exercise in Rat.Reduced hexokinase II impairs muscle function 2 wk after ischemia-reperfusion through increased cell necrosis and fibrosis.The effect of standard chow and reduced hexokinase II on growth, cardiac and skeletal muscle hexokinase and low-flow cardiac ischaemia-reperfusion injury.Insulin regulates POMC neuronal plasticity to control glucose metabolism
P2860
Q28592204-B1564259-9CF0-4835-BBF9-405B698364F7Q34448802-736B2750-7B5D-4E15-9F23-ED893A57D046Q34474251-EC774F26-B05F-4835-B094-D3E7116C5E1EQ35576497-625617A4-4B2D-491F-9848-B7183D76D0A0Q36320932-AEFEA35D-28B4-4F49-B170-C9589E3F3D13Q36923620-F8424407-897B-4F3D-86C4-BFF9D501AD16Q37086438-1B093A98-3367-4B06-B762-044B6F670426Q37264198-E6D0AA70-8A15-4884-88A0-ED0968E6F888Q37357426-52BDF2DB-D082-40AB-BA67-0A54FC070815Q37416560-20BB47A0-B35D-4E4D-B3B9-62C34CBED51FQ41433276-860942C0-EC0D-4494-B80B-1FB96A0B8F7AQ53093069-848982FA-F901-49F1-9882-2DD6CFC213D8Q54502504-59F8B367-E0C6-41AE-B17D-B43148B289E1Q54595621-5C95AE2C-1692-4B73-808B-F5CE81B14ADAQ58715405-61066C7C-A6B3-4A1C-8969-88014320FF6C
P2860
Phosphorylation barriers to skeletal and cardiac muscle glucose uptakes in high-fat fed mice: studies in mice with a 50% reduction of hexokinase II
description
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
artículu científicu espublizáu en 2007
@ast
im Oktober 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 2007/10/01)
@sk
vědecký článek publikovaný v roce 2007
@cs
wetenschappelijk artikel (gepubliceerd op 2007/10/01)
@nl
наукова стаття, опублікована в жовтні 2007
@uk
مقالة علمية (نشرت في أكتوبر 2007)
@ar
name
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@ast
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@en
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@nl
type
label
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@ast
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@en
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@nl
prefLabel
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@ast
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@en
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@nl
P2093
P921
P3181
P356
P1433
P1476
Phosphorylation barriers to sk ...... 50% reduction of hexokinase II
@en
P2093
David H. Wasserman
Deanna P. Bracy
Jane Shearer
Jeffrey N. Rottman
Patrick T. Fueger
Robert S. Lee-Young
Sami Heikkinen
P304
P3181
P356
10.2337/DB07-0532
P407
P577
2007-10-01T00:00:00Z